TABLE 3.
No of studies | RR (95% CI) | I2 (%) | P-value for heterogeneity | P-value between groups | ||
Study location | 0.648 | |||||
Asia | 4 | 1.24 (1.07, 1.43) | 21.7 | 0.280 | ||
North America | 9 | 1.07 (1.01, 1.14) | 89.4 | <0.001 | ||
Europe | 5 | 1.11 (1.04, 1.18) | 67.7 | 0.015 | ||
During COVID-19 pandemic | 0.101 | |||||
Not | 16 | 1.12 (1.07, 1.18) | 82.6 | <0.001 | ||
Yes | 2 | 0.98 (0.85, 1.14) | 83.2 | 0.015 | ||
Depression at baseline | 0.530 | |||||
Excluded | 12 | 1.11 (1.06, 1.16) | 66.0 | 0.001 | ||
Included | 6 | 1.07 (1.00, 1.15) | 85.4 | <0.001 | ||
Sample size | 0.221 | |||||
<5,000 | 13 | 1.14 (1.07, 1.22) | 73.4 | <0.001 | ||
>5,000 | 5 | 1.06 (1.00, 1.13) | 92.5 | <0.001 | ||
Study quality | 0.287 | |||||
Low quality | 4 | 1.03 (0.96, 1.10) | 90.6 | <0.001 | ||
Medium quality | 12 | 1.17 (1.09, 1.25) | 56.8 | 0.008 | ||
High quality | 2 | 1.10 (1.06, 1.12) | 0 | 0.397 | ||
Follow-up time | 0.580 | |||||
<60 months | 12 | 1.09 (1.03, 1.15) | 79.4 | <0.001 | ||
>60 months | 6 | 1.11 (1.06, 1.16) | 64.2 | 0.016 | ||
Screen time in the control group | 0.037 | |||||
Continuous | 4 | 1.05 (1.01, 1.09) | 64.8 | 0.036 | ||
≤1 h/day | 7 | 1.12 (1.06, 1.18) | 50.3 | 0.060 | ||
>1 h/day | 4 | 1.22 (1.09, 1.36) | 0 | 0.722 | ||
Physical activity adjusted | ||||||
Yes | 8 | 1.11 (1.01, 1.22) | 83.4 | 0.001 | 0.774 | |
No | 10 | 1.10 (1.06, 1.14) | 68.3 | <0.001 | ||
Sex | 0.867 | |||||
Mix | 12 | 1.10 (1.06, 1.14) | 74.6 | <0.001 | ||
Female | 7 | 1.15 (1.01, 1.31) | 76.2 | 0.001 | ||
Male | 5 | 1.12 (0.89, 1.42) | 77.4 | 0.004 | ||
Gender | 0.429 | |||||
0–20 | 7 | 1.18 (1.04, 1.34) | 86.0 | <0.001 | ||
20–44 | 8 | 1.08 (1.05, 1.12) | 61.0 | 0.012 | ||
>44 | 3 | 1.09 (0.92, 1.30) | 88.4 | <0.001 | ||
Screen equipment | 0.689 | |||||
Screen not specific | 6 | 1.06 (1.00, 1.13) | 70.5 | 0.005 | ||
Using mobile phone | 4 | 1.13 (1.01, 1.25) | 57.7 | 0.069 | ||
Watching TV | 8 | 1.13 (1.06, 1.21) | 65.0 | 0.006 | ||
Using computer | 8 | 1.09 (0.99, 1.20) | 89.1 | <0.001 |